ArticleThe AAPS journal2026

Physiologically based Biopharmaceutics Modeling (PBBM) Reveals a Low Dissolution-related Bioequivalence Risk for Immediate-Release Amlodipine Tablets.

Porfirio de la Cruz Cruz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.